In-situ stable injectable collagen-based hydrogels for cell and growth factor delivery

Seyedsina Moeinzadeh; Youngbum Park; Sien Lin; Yunzhi Peter Yang

doi:10.1016/j.mtla.2020.100954

In-situ stable injectable collagen-based hydrogels for cell and growth factor delivery

Seyedsina Moeinzadeh, Youngbum Park, Sien Lin, Yunzhi Peter Yang

Department of Prosthodontics

Research output: Contribution to journal › Article › peer-review

15 Citations (Scopus)

Abstract

Here we report development of in-situ stable injectable hydrogels for delivery of cells and growth factors based on two precursors, alginate, and collagen/calcium sulfate (CaSO₄). The alg/col hydrogels were shear-thinning, injectable through commercially available needles and stable right after injection. Rheological measurements revealed that pre-crosslinked alg/col hydrogels fully crosslinked at 37 °C and that the storage modulus of alg/col hydrogels increased with increasing the collagen content or the concentration of CaSO₄. The viscoelastic characteristics and injectability of the alg/col hydrogels were not significantly impacted by the storage of precursor solutions for 28 days. An osteoinductive bone morphogenic protein-2 (BMP-2) loaded into alg/col hydrogels was released in 14 days. Human mesenchymal stem cells (hMSCs) encapsulated in alg/col hydrogels had over 90% viability over 7 days after injection. The DNA content of hMSC-laden alg/col hydrogels increased by 6-37 folds for 28 days, depending on the initial cell density. In addition, hMSCs encapsulated in alg/col hydrogels and incubated in osteogenic medium were osteogenically differentiated and formed a mineralized matrix. Finally, a BMP-2 loaded alg/col hydrogel was used to heal a critical size calvarial bone defect in rats after 8 weeks of injection. The alg/col hydrogel holds great promise in tissue engineering and bioprinting applications.

Original language	English
Article number	100954
Journal	Materialia
Volume	15
DOIs	https://doi.org/10.1016/j.mtla.2020.100954
Publication status	Published - 2021 Mar

Bibliographical note

Funding Information:
This research was funded through financial support from NIH grants R01AR057837, U01AR069395, R01AR072613, and R01AR074458 from NIAMS, and DoD grant W81XWH-20-1-0343. Dr. YoungBum Park is in charge of the in vivo study and a co-corresponding author for the animal experiments in this manuscript. The MicroCT (Bruker Skyscan 1276) instrument was purchased using NIH S10 Shared Instrumentation Grant (1S10OD02349701, PI Timothy C. Doyle). All data supporting the findings of this study are available within the paper and its supplementary file.

Publisher Copyright:
© 2020

All Science Journal Classification (ASJC) codes

Materials Science(all)

Access to Document

10.1016/j.mtla.2020.100954

Cite this

@article{a95ea408a9db4ade98bd61570f4d5aa8,

title = "In-situ stable injectable collagen-based hydrogels for cell and growth factor delivery",

abstract = "Here we report development of in-situ stable injectable hydrogels for delivery of cells and growth factors based on two precursors, alginate, and collagen/calcium sulfate (CaSO4). The alg/col hydrogels were shear-thinning, injectable through commercially available needles and stable right after injection. Rheological measurements revealed that pre-crosslinked alg/col hydrogels fully crosslinked at 37 °C and that the storage modulus of alg/col hydrogels increased with increasing the collagen content or the concentration of CaSO4. The viscoelastic characteristics and injectability of the alg/col hydrogels were not significantly impacted by the storage of precursor solutions for 28 days. An osteoinductive bone morphogenic protein-2 (BMP-2) loaded into alg/col hydrogels was released in 14 days. Human mesenchymal stem cells (hMSCs) encapsulated in alg/col hydrogels had over 90% viability over 7 days after injection. The DNA content of hMSC-laden alg/col hydrogels increased by 6-37 folds for 28 days, depending on the initial cell density. In addition, hMSCs encapsulated in alg/col hydrogels and incubated in osteogenic medium were osteogenically differentiated and formed a mineralized matrix. Finally, a BMP-2 loaded alg/col hydrogel was used to heal a critical size calvarial bone defect in rats after 8 weeks of injection. The alg/col hydrogel holds great promise in tissue engineering and bioprinting applications.",

author = "Seyedsina Moeinzadeh and Youngbum Park and Sien Lin and Yang, {Yunzhi Peter}",

note = "Funding Information: This research was funded through financial support from NIH grants R01AR057837, U01AR069395, R01AR072613, and R01AR074458 from NIAMS, and DoD grant W81XWH-20-1-0343. Dr. YoungBum Park is in charge of the in vivo study and a co-corresponding author for the animal experiments in this manuscript. The MicroCT (Bruker Skyscan 1276) instrument was purchased using NIH S10 Shared Instrumentation Grant (1S10OD02349701, PI Timothy C. Doyle). All data supporting the findings of this study are available within the paper and its supplementary file. Publisher Copyright: {\textcopyright} 2020",

year = "2021",

month = mar,

doi = "10.1016/j.mtla.2020.100954",

language = "English",

volume = "15",

journal = "Materialia",

issn = "2589-1529",

publisher = "Elsevier BV",

}

TY - JOUR

T1 - In-situ stable injectable collagen-based hydrogels for cell and growth factor delivery

AU - Moeinzadeh, Seyedsina

AU - Park, Youngbum

AU - Lin, Sien

AU - Yang, Yunzhi Peter

N1 - Funding Information: This research was funded through financial support from NIH grants R01AR057837, U01AR069395, R01AR072613, and R01AR074458 from NIAMS, and DoD grant W81XWH-20-1-0343. Dr. YoungBum Park is in charge of the in vivo study and a co-corresponding author for the animal experiments in this manuscript. The MicroCT (Bruker Skyscan 1276) instrument was purchased using NIH S10 Shared Instrumentation Grant (1S10OD02349701, PI Timothy C. Doyle). All data supporting the findings of this study are available within the paper and its supplementary file. Publisher Copyright: © 2020

PY - 2021/3

Y1 - 2021/3

N2 - Here we report development of in-situ stable injectable hydrogels for delivery of cells and growth factors based on two precursors, alginate, and collagen/calcium sulfate (CaSO4). The alg/col hydrogels were shear-thinning, injectable through commercially available needles and stable right after injection. Rheological measurements revealed that pre-crosslinked alg/col hydrogels fully crosslinked at 37 °C and that the storage modulus of alg/col hydrogels increased with increasing the collagen content or the concentration of CaSO4. The viscoelastic characteristics and injectability of the alg/col hydrogels were not significantly impacted by the storage of precursor solutions for 28 days. An osteoinductive bone morphogenic protein-2 (BMP-2) loaded into alg/col hydrogels was released in 14 days. Human mesenchymal stem cells (hMSCs) encapsulated in alg/col hydrogels had over 90% viability over 7 days after injection. The DNA content of hMSC-laden alg/col hydrogels increased by 6-37 folds for 28 days, depending on the initial cell density. In addition, hMSCs encapsulated in alg/col hydrogels and incubated in osteogenic medium were osteogenically differentiated and formed a mineralized matrix. Finally, a BMP-2 loaded alg/col hydrogel was used to heal a critical size calvarial bone defect in rats after 8 weeks of injection. The alg/col hydrogel holds great promise in tissue engineering and bioprinting applications.

AB - Here we report development of in-situ stable injectable hydrogels for delivery of cells and growth factors based on two precursors, alginate, and collagen/calcium sulfate (CaSO4). The alg/col hydrogels were shear-thinning, injectable through commercially available needles and stable right after injection. Rheological measurements revealed that pre-crosslinked alg/col hydrogels fully crosslinked at 37 °C and that the storage modulus of alg/col hydrogels increased with increasing the collagen content or the concentration of CaSO4. The viscoelastic characteristics and injectability of the alg/col hydrogels were not significantly impacted by the storage of precursor solutions for 28 days. An osteoinductive bone morphogenic protein-2 (BMP-2) loaded into alg/col hydrogels was released in 14 days. Human mesenchymal stem cells (hMSCs) encapsulated in alg/col hydrogels had over 90% viability over 7 days after injection. The DNA content of hMSC-laden alg/col hydrogels increased by 6-37 folds for 28 days, depending on the initial cell density. In addition, hMSCs encapsulated in alg/col hydrogels and incubated in osteogenic medium were osteogenically differentiated and formed a mineralized matrix. Finally, a BMP-2 loaded alg/col hydrogel was used to heal a critical size calvarial bone defect in rats after 8 weeks of injection. The alg/col hydrogel holds great promise in tissue engineering and bioprinting applications.

UR - http://www.scopus.com/inward/record.url?scp=85097350534&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85097350534&partnerID=8YFLogxK

U2 - 10.1016/j.mtla.2020.100954

DO - 10.1016/j.mtla.2020.100954

M3 - Article

AN - SCOPUS:85097350534

VL - 15

JO - Materialia

JF - Materialia

SN - 2589-1529

M1 - 100954

ER -

In-situ stable injectable collagen-based hydrogels for cell and growth factor delivery

Abstract

Bibliographical note

All Science Journal Classification (ASJC) codes

Access to Document

Other files and links

Fingerprint

Cite this